<SEC-DOCUMENT>0001839882-22-002943-index.html : 20220214
<SEC-HEADER>0001839882-22-002943.hdr.sgml : 20220214
<ACCEPTANCE-DATETIME>20220214172947
ACCESSION NUMBER:		0001839882-22-002943
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20220214
DATE AS OF CHANGE:		20220214

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ovid Therapeutics Inc.
		CENTRAL INDEX KEY:			0001636651
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				465270895
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-90350
		FILM NUMBER:		22635227

	BUSINESS ADDRESS:	
		STREET 1:		1460 BROADWAY
		STREET 2:		SUITE 15044
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036
		BUSINESS PHONE:		212-776-4381

	MAIL ADDRESS:	
		STREET 1:		1460 BROADWAY
		STREET 2:		SUITE 15044
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			During Matthew
		CENTRAL INDEX KEY:			0001704631

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	MAIL ADDRESS:	
		STREET 1:		C/O OVID THERAPEUTICS INC.
		STREET 2:		1460 BROADWAY, SUITE 15044
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>during-sc13ga_123121.htm
<DESCRIPTION>AMENDMENT TO FORM SC 13G
<TEXT>
Document 1 - file: during-sc13ga_123121.htm

</DOCUMENT>
</SEC-DOCUMENT>